Drug Type Small molecule drug |
Synonyms FR158999 |
Target |
Mechanism Fibrinogen inhibitors, GP IIb/IIIa antagonists(Integrin alpha-IIb/beta-3 antagonists), Platelet aggregation inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H35N5O8S |
InChIKeyFPOQHPVEVPIFME-RXVVDRJESA-N |
CAS Registry160138-41-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Thrombosis | Phase 1 | - | - |